Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains.

Saved in:
Bibliographic Details
Title: Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains.
Authors: AlAmri MA; School of Pharmacy, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Kadri H; School of Pharmacy, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Alderwick LJ; Birmingham Drug Discovery Facility, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Simpkins NS; School of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Mehellou Y; School of Pharmacy and Pharmaceutical Sciences, Redwood Building, Cardiff University, Cardiff, CF10 3NB, UK.
Source: ChemMedChem [ChemMedChem] 2017 May 09; Vol. 12 (9), pp. 639-645. Date of Electronic Publication: 2017 Apr 12.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1860-7187
DOI:10.1002/cmdc.201700077